Youtube, in a tweet on Friday, has announced to block Russian YouTube channels that spread misinformation regarding the Russia-Ukraine conflict.
The google-owned video-sharing platform has...
Russia's Sputnik V vaccine has demonstrated 96.3% efficacy against COVID-19 during the vaccination campaign in Belarus, Russia's RDIF sovereign wealth fund said on Wednesday,...
The World Health Organization said on Thursday it was about to restart the process of approving Russia's Sputnik V Covid-19 vaccine following a series...
The United Arab Emirates has authorised the Russia-developed one-shot Sputnik Light as both a standalone COVID-19 vaccine and a booster shot, Russia's sovereign fund...
All the barriers to register Russia's Sputnik V COVID-19 vaccine with the World Health Organization (WHO) have been cleared and only some paperwork remains...
A small-scale clinical study of the combined use of the AstraZeneca and Sputnik Light vaccines against COVID-19 has shown strong antibody growth in a...
LAHORE: Pakistan has begun free of cost administration of Russia's Sputnik vaccine at a Lahore COVID vaccination centre as previously private health institutes were...
Russia's Sputnik V vaccine against COVID-19 is around 83% effective against the Delta variant of coronavirus, lower than previously thought, Health Minister Mikhail Murashko...
Russia's Sputnik V coronavirus vaccine was the first to arrive in Argentina in December 2020 with the promise of relief for Latin American countries...
Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca's shot revealed no serious side effects and no subsequent cases of...
Russia's Sputnik V vaccine against COVID-19 is around 90% effective against the highly contagious Delta variant of coronavirus, its developers said on Tuesday.
The shot,...
The concerns relate to the Pharmstandard-UfaVITA plant, one of four Sputnik V production and filling sites that were reviewed, the WHO said in its preliminary report.
The Sputnik V vaccine is based on a proven and well-studied platform of human adenoviral vectors, which cause the common cold and have been around for thousands of years
It is the latest evidence that some EU companies are not willing to wait for the EU’s own regulator -- the European Medicines Agency (EMA) -- to grant its approval to Sputnik V
A Russian trial testing the effectiveness of revaccination with the Sputnik V shot to protect against new mutations of the coronavirus is producing strong results